NVAX earnings
Novavax (NVAX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
NVAX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.32 | -0.38 | 15.75% | $56.70M |
| Q1 2026 | May 6, 2026 | -0.06 | -0.25 | 76.00% | $139.51M |
| Q4 2025 | Feb 26, 2026 | 0.11 | -0.66 | 116.67% | $147.14M |
| Q3 2025 | Nov 6, 2025 | -1.25 | -1.08 | -15.74% | $70.44M |
| Q2 2025 | Aug 6, 2025 | 0.62 | -0.07 | 985.71% | $239.24M |
| Q1 2025 | May 8, 2025 | 2.93 | 0.71 | 312.68% | $666.65M |
| Q4 2024 | Feb 27, 2025 | -0.51 | -0.75 | 32.00% | $88.31M |
| Q3 2024 | Nov 12, 2024 | -0.76 | -0.87 | 12.64% | $84.51M |
| Q2 2024 | Aug 8, 2024 | 0.99 | 1.64 | -39.63% | $415.48M |
| Q1 2024 | May 10, 2024 | -1.05 | -1.04 | -0.96% | $93.86M |
| Q4 2023 | Feb 28, 2024 | -1.44 | -0.49 | -193.88% | $291.34M |
| Q3 2023 | Nov 9, 2023 | -1.26 | -1.82 | 30.77% | $22.06M |
| Aug 8, 2023 | 0.58 | -1.39 | 141.73% | – | |
| May 9, 2023 | -3.41 | -3.38 | -0.89% | – | |
| Feb 28, 2023 | -2.28 | -0.92 | -147.83% | – | |
| Nov 8, 2022 | -2.15 | 2.21 | -197.29% | – | |
| Aug 8, 2022 | -6.53 | 5.51 | -218.51% | – | |
| May 9, 2022 | 2.56 | 2.69 | -4.83% | – | |
| Feb 28, 2022 | -11.18 | -1.43 | -681.82% | – | |
| Nov 4, 2021 | -4.31 | -4.04 | -6.68% | – |
- NVAX reports next on Nov 5, 2026, with EPS of -0.22 expected.
- NVAX beat EPS estimates in 51 of its last 105 reports.
Updated 2026-11-02 23:14 UTC